Honored with the UAB SoE 2024-2025 Innovation Fellowship Award for Neuromodulation Technology Development, Oct. 2024
I am thrilled to announce that I have been honored with the SOE 2024-2025 Innovation Fellowship Award from the UAB School of Engineering Innovation Fellows for our project titled “Transformative Brain Transcranial Electrical Stimulation via Hall-Effect Based Current Steering for Neurological Disease”.
Our project is at the forefront of medical innovation, aiming to introduce a novel method for directing and controlling electrical stimulation currents in the brain using the Hall-Effect phenomenon to treat neurological disorders. It combines principles of electrical and magnetic field physics with advanced hardware and is powered by an Artificial Intelligence (AI) machine learning (ML) core. Transcranial Electrical Stimulation (TES), such as Transcranial Direct Current Stimulation (tDCS), has demonstrated significant clinical effectiveness in enhancing learning and treating various neurological conditions.
This award is a testament to our commitment to innovation and the potential impact of our neuroscience research. I am deeply grateful for this recognition and excited about the opportunities it presents for advancing healthcare and improving lives globally.
NSF CAREER Award for Advancing Precision Ablation and Cancer Treatment, 2024
I am honored to announce that I have been awarded the prestigious National Science Foundation (NSF) CAREER grant. This award supports the project titled “Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation”.
This innovative project addresses a critical challenge in cancer treatment by enhancing the precision of thermal ablation technology by effectively target tumors while preserving surrounding healthy tissues. The project will focus on Tumor Precision Ablation (TPA), a technique designed to precisely control the dispersion of heat in tissues, crucial for treating asymmetrically shaped tumors. This research is particularly vital for treating brain tumors and diseases where tissue ablation is a key therapeutic strategy, including liver, lung, kidney, and bone tumors, epilepsy foci, motor circuits in movement disorders, and vascular abnormalities in the brain.
Our approach involves developing a novel ablation catheter, a first in its field, which tackles specific scientific challenges in modulating heat penetration and direction during thermal ablation procedures. The project is anticipated to significantly influence the fields of microelectronics, heat transfer, and tumor treatment, opening new avenues in precision medicine research and development.
Integral to this project is an educational plan designed to involve students from underrepresented groups in STEM. Interdisciplinary courses will be developed that intersect with majors such as electrical engineering, biomedical engineering, and oncology, offering research opportunities for undergraduate and graduate students. Additionally, outreach activities will be organized to share resources, tools, and knowledge with teachers and students, amplifying the project’s impact.
Honored with the UAB, SoE, ECE Department, Promoting ECE Mission Award, 2024
Honored with the UAB SoE 2024-2025 Innovation Fellowship Award for Diabetes Implant Design, Jan. 2024
I am thrilled to announce that I have been honored with the SOE 2024-2025 Innovation Fellowship Award by the UAB School of Engineering Innovation Fellows, for our project titled “Wireless Vagus Nerve Implant for Diabetes Reversal”.
Our project stands at the forefront of medical innovation, aiming to transform diabetes management through a pioneering approach. We are exploring the electrical patterns of the vagus nerve in the stomach and its role in diabetes, with the goal of designing a groundbreaking, miniaturized, and fully wireless implant. This device, which is flexible, biocompatible, and integrated with machine learning algorithms, seeks to offer an effective strategy for diabetes management and reversal without the need for drugs or insulin.
By providing a drug-free solution to diabetes, we aim not only to enhance the quality of life for millions of individuals worldwide but also to open new avenues for understanding and addressing a range of metabolic disorders, including Type 1 Diabetes, prediabetes, obesity, and more.
This award is a testament to our commitment to innovation and the potential impact of our research. I am deeply grateful for this recognition and excited about the opportunities it presents for advancing healthcare and improving lives around the globe.
NeuroGateways 2023 Symposium, UAB, March 30-31, 2023
https://www.neurogateways.com/
